SOMAXON PHARMACEUTICALS, INC.

SAN DIEGO, CA How do I update this listing?

Somaxon Pharmaceuticals is based out of San Diego. Operates as a development stage specialty pharmaceutical company. Focuses on the in-licensing and development of proprietary product candidates for the treatment of diseases and disorders in the fields of psychiatry and neurology.Whalewisdom has at least 1 13G filings, and 63 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2009-07-15. The notice included securities offered of Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security

Create Alert

Contact Info

somaxon pharmaceuticals, inc.
10935 VISTA SORRENTO PARKWAY
SAN DIEGO CA    92130

Business Phone: (858) 876-6500
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2009-07-15 D PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 5,999,990 5,999,990 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
BRIAN T. DORSEY subscription required
    EXECUTIVE OFFICER
DAVID F. HALE subscription required
    DIRECTOR
ERLE T. MAST subscription required
    DIRECTOR
JEFFREY W. RASER subscription required
    EXECUTIVE OFFICER
JESSE I. TREU subscription required
    DIRECTOR
KURT VON EMSTER subscription required
    DIRECTOR
KURT C. WHEELER subscription required
    DIRECTOR
MATTHEW W. ONAITIS subscription required
    EXECUTIVE OFFICER
MICHAEL L. EAGLE subscription required
    DIRECTOR
RICHARD W. PASCOE subscription required
    EXECUTIVE OFFICER DIRECTOR
TERRELL A. COBB subscription required
    DIRECTOR
THOMAS G. WIGGANS subscription required
    DIRECTOR

Elevate your investments